Paper35450076
Liraglutide Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating Macrophage Polarization.
Li SL and 11 others. Front Immunol, 2022. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Liraglutide Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating Macrophage Polarization. Papers, record 35450076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35450076
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liraglutide Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating Macrophage Polarization.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Reperfusion Injury | Major topic |
| Animals | |
| Lipopolysaccharides | |
| Liraglutide | |
| Liver | |
| Macrophages | |
| Mice | |
| Mice, Inbred C57BL |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32478287 | Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis. | Nat Metab | 2020 | https://conductscience.org/library/papers/32478287 | PubMed |
| 2 | 29530599 | The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis. | Pharmacol Res | 2018 | https://conductscience.org/library/papers/29530599 | PubMed |
| 3 | 11425059 | Hepatic ischemia-reperfusion injury. | Am J Surg | 2001 | https://conductscience.org/library/papers/11425059 | PubMed |
| 4 | 19029990 | Exploring the full spectrum of macrophage activation. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/19029990 | PubMed |
| 5 | 28270843 | Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis. | J Geriatr Cardiol | 2017 | https://conductscience.org/library/papers/28270843 | PubMed |
| 6 | 32711187 | The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet. | Transl Res | 2021 | https://conductscience.org/library/papers/32711187 | PubMed |
| 7 | 27255130 | Hepatic ischemia reperfusion injury: A systematic review of literature and the role of current drugs and biomarkers. | Int J Surg | 2016 | https://conductscience.org/library/papers/27255130 | PubMed |
| 8 | 33526969 | Macrophage Polarization and Liver Ischemia-Reperfusion Injury. | Int J Med Sci | 2021 | https://conductscience.org/library/papers/33526969 | PubMed |
| 9 | 20856220 | Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. | Nat Immunol | 2010 | https://conductscience.org/library/papers/20856220 | PubMed |
| 10 | 28893351 | Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair, and Regeneration. | Gene Expr | 2017 | https://conductscience.org/library/papers/28893351 | PubMed |
| 11 | 28317925 | Liver macrophages in tissue homeostasis and disease. | Nat Rev Immunol | 2017 | https://conductscience.org/library/papers/28317925 | PubMed |
| 12 | 17764614 | The roles of innate immune cells in liver injury and regeneration. | Cell Mol Immunol | 2007 | https://conductscience.org/library/papers/17764614 | PubMed |
| 13 | 24115204 | Macrophage plasticity and polarization in liver homeostasis and pathology. | Hepatology | 2014 | https://conductscience.org/library/papers/24115204 | PubMed |
| 14 | 24799983 | Global consequences of liver ischemia/reperfusion injury. | Oxid Med Cell Longev | 2014 | https://conductscience.org/library/papers/24799983 | PubMed |
| 15 | 21668640 | Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. | Am J Transplant | 2011 | https://conductscience.org/library/papers/21668640 | PubMed |
| 16 | 25058854 | Liver ischemia/reperfusion injury: an overview. | J Invest Surg | 2014 | https://conductscience.org/library/papers/25058854 | PubMed |
| 17 | 23640482 | Transcriptional control of macrophage polarization. | Arterioscler Thromb Vasc Biol | 2013 | https://conductscience.org/library/papers/23640482 | PubMed |
| 18 | 33764625 | miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy. | Am J Transplant | 2021 | https://conductscience.org/library/papers/33764625 | PubMed |
| 19 | 8596407 | Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. | Lancet | 1996 | https://conductscience.org/library/papers/8596407 | PubMed |
| 20 | 27636208 | Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity. | Obes Rev | 2017 | https://conductscience.org/library/papers/27636208 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42870021 | Liraglutide ameliorates obese type 2 diabetes by regulating macrophage cholesterol metabolism and H3K27ac modification to promote M2 polarization and adipocyte thermogenic activation. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42870021 | PubMed |
| 42808829 | Study on the Regulatory Mechanism of GLP-1 Receptor Agonist Liraglutide in Diabetic Corneal Epithelial Wound Healing. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42808829 | PubMed |
| 42737442 | Liraglutide Attenuates Multiorgan Oxidative, Astroglial, and Mitochondrial Stress Responses in Thioacetamide-Induced Hepatic Encephalopathy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737442 | PubMed |
| 42521944 | GLP-1 receptor agonists at the crossroads of diabetes, hepatic steatosis, and hepatocellular carcinoma. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/42521944 | PubMed |
| 42205663 | Semaglutide and Its Potential Hepatoprotective Effects Against Acute Drug-Induced Liver Injury. | Cureus | 2026 | https://conductscience.org/library/papers/42205663 | PubMed |
| 42004943 | Immunometabolic remodeling: new perspectives and strategies for liver transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42004943 | PubMed |
| 41939830 | The mechanisms of GLP-1 receptor agonists in liver diseases: their multifaceted impact on immune response and metabolic regulation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41939830 | PubMed |
| 41901255 | GLP-1 RAs for Treating Metabolic Dysfunction-Associated Steatosis Liver Disease: From GLP-1 Discovery to FDA Approval: A Comprehensive Narrative Review. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901255 | PubMed |
| 41779082 | Silencing of HAVCR2 Attenuates Skeletal Muscle Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress. | Biochem Genet | 2026 | https://conductscience.org/library/papers/41779082 | PubMed |
| 41683648 | Plasma GLP-1 (Glucagon-like Peptide-1) Depletion Is Correlated with Dysregulation of Adipocytokine in Type 2 Diabetic Patients With or Without Metabolic-Associated Fatty Liver Disease (MAFLD): A Cross-Sectional Study Related to Gender-Sex Disparities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683648 | PubMed |
| 41664131 | Inhalation of mesenchymal stromal cell-derived extracellular vesicles activates macrophage polarization through the miR-22-3p/NLRP3/IL-1β pathway, ameliorating lung ischemia - reperfusion injury. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/41664131 | PubMed |
| 41659879 | Mechanistic insights into neutrophil involvement in liver transplant ischemia-reperfusion injury and rejection. | Front Immunol | 2026 | https://conductscience.org/library/papers/41659879 | PubMed |
| 41640618 | Targeting Jun N-terminal kinase phosphorylation: A human-derived hepatoprotective peptide human liver transplantation peptide 1 attenuates hepatic ischemia-reperfusion injury. | World J Gastroenterol | 2026 | https://conductscience.org/library/papers/41640618 | PubMed |
| 41626528 | Liraglutide prevents lupus-associated diffuse alveolar hemorrhage via inhibiting lymphocyte infiltration and promoting macrophage M2 polarization. | J Transl Autoimmun | 2026 | https://conductscience.org/library/papers/41626528 | PubMed |
| 41578328 | Acteoside prevents high-fat diet-induced obesity by regulating brown adipose tissue production, lipid metabolism, and the gut microbiota. | Eur J Med Res | 2026 | https://conductscience.org/library/papers/41578328 | PubMed |
| 41491215 | Endothelial-targeted modification of ginseng-derived exosomes for IL-6 SiRNA delivery ameliorates hepatic ischemia-reperfusion injury. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41491215 | PubMed |
| 41304982 | The GLP-1 Analog Liraglutide Reduces Fever Through Sex-Dependent Neuroinflammatory Modulation. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304982 | PubMed |
| 40909285 | Comprehensive review of macrophage models: primary cells and immortalized lines across species. | Front Immunol | 2025 | https://conductscience.org/library/papers/40909285 | PubMed |
| 40728098 | Alleviative Effects of Ciprofol on Hepatic Ischemia/Reperfusion Injury Through Inhibiting Macrophage Polarization. | Immun Inflamm Dis | 2025 | https://conductscience.org/library/papers/40728098 | PubMed |
| 40671163 | Mechanism of miR-107/HMOX1 axis in hepatic sinusoidal endothelial cells stimulated by ischemia-reperfusion injury. | Hereditas | 2025 | https://conductscience.org/library/papers/40671163 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35450076
GET https://conductscience.org/api/papers/v1/35450076/references?page=2